Chroma Medicine Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 50

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $75M

  • Investors
  • 2

Chroma Medicine General Information

Description

Developer of genomic medicines designed to revolutionize the treatment of genetically driven diseases. The company's medicines harness epigenetics, nature's innate mechanism for gene regulation programmable epigenetic editors to target genes and control chromatin conformation by coupling a DNA binding domain with epigenetic effector domains, enabling medical practitioners to have a class of therapeutics to achieve unparalleled control of gene expression.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 201 Brookline Avenue
  • Suite 1101
  • Boston, MA 02215
  • United States
+1 (617)
Primary Industry
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • 201 Brookline Avenue
  • Suite 1101
  • Boston, MA 02215
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Chroma Medicine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 04-Dec-2024 $75M Completed Out of Business
3. Early Stage VC (Series B) 08-Feb-2023 Completed Generating Revenue
2. Early Stage VC (Series A) 12-Oct-2021 $101M $127M Completed Generating Revenue
1. Seed Round 01-Jan-2021 $26.3M $26.3M Completed Generating Revenue
To view Chroma Medicine’s complete valuation and funding history, request access »

Chroma Medicine Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
Seed 24,583,572 $0.000100 $0.06 $1.07 $1.07 1x $1.07 14.05%
To view Chroma Medicine’s complete cap table history, request access »

Chroma Medicine Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of genomic medicines designed to revolutionize the treatment of genetically driven diseases. The company's med
Drug Discovery
Boston, MA
50 As of 2026

Cambridge, MA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Chroma Medicine Competitors (3)

One of Chroma Medicine’s 3 competitors is Intellia Therapeutics, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Intellia Therapeutics Formerly VC-backed Cambridge, MA
Neuron23 Venture Capital-Backed South San Francisco, CA
Casma Therapeutics Venture Capital-Backed Cambridge, MA
You’re viewing 3 of 3 competitors. Get the full list »

Chroma Medicine Patents

Chroma Medicine Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026102011-A1 Compositions and methods for epigenetic regulation of gene expression Pending 05-Nov-2024
WO-2026090544-A1 Gene silencing Pending 24-Oct-2024
WO-2025049789-A1 Compositions and methods for epigenetic regulation of adora2a expression Inactive 01-Sep-2023
WO-2025049792-A1 Compositions and methods for epigenetic regulation of tgfbr2 expression Inactive 01-Sep-2023
WO-2025038840-A1 Compositions and methods for epigenetic editing Inactive 16-Aug-2023 C12N9/0071
To view Chroma Medicine’s complete patent history, request access »

Chroma Medicine Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Chroma Medicine Former Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
ARCH Venture Partners Venture Capital Minority
Alexandria Real Estate Equities Real Estate Minority
Atlas Venture Venture Capital Minority
Casdin Capital Venture Capital Minority
Cormorant Asset Management PE/Buyout Minority
You’re viewing 5 of 15 investors. Get the full list »

Chroma Medicine Acquisitions (1)

Chroma Medicine’s most recent deal was a Merger/Acquisition with Epsilen Bio. The deal was made on 17-Nov-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Epsilen Bio 17-Nov-2021 Merger/Acquisition Drug Discovery
To view Chroma Medicine’s complete acquisitions history, request access »

Chroma Medicine FAQs

  • When was Chroma Medicine founded?

    Chroma Medicine was founded in 2020.

  • Where is Chroma Medicine headquartered?

    Chroma Medicine is headquartered in Boston, MA.

  • What is the size of Chroma Medicine?

    Chroma Medicine has 50 total employees.

  • What industry is Chroma Medicine in?

    Chroma Medicine’s primary industry is Drug Discovery.

  • Is Chroma Medicine a private or public company?

    Chroma Medicine is a Private company.

  • What is the current valuation of Chroma Medicine?

    The current valuation of Chroma Medicine is .

  • What is Chroma Medicine’s current revenue?

    The current revenue for Chroma Medicine is .

  • How much funding has Chroma Medicine raised over time?

    Chroma Medicine has raised $262M.

  • Who are Chroma Medicine’s investors?

    ARCH Venture Partners, Alexandria Real Estate Equities, Atlas Venture, Casdin Capital, and Cormorant Asset Management are 5 of 15 investors who have invested in Chroma Medicine.

  • Who are Chroma Medicine’s competitors?

    Intellia Therapeutics, Neuron23, and Casma Therapeutics are competitors of Chroma Medicine.

  • When was Chroma Medicine acquired?

    Chroma Medicine was acquired on 04-Dec-2024.

  • Who acquired Chroma Medicine?

    Chroma Medicine was acquired by nChroma Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process